A retrospective German study found that totally endoscopic chordal-sparing mitral valve replacement was needed in 7.2% of 1,037 operations and produced acceptable mid-term results in selected patients ...

A multimodal transformer-based AI framework achieved an AUC of 0.727 on preoperative endoscopic biopsy slides for predicting ...

When I say I have been a surgeon for a long time, people sometimes assume I must have spent my career performing cutting-edge ...

Families coming to Boston seeking life-saving care often stay for weeks or months, hunting to find affordable rooms in one of the country’s most expensive cities.

Olympus received a U.S. FDA Warning Letter in October 2026 citing quality management system deficiencies at six facilities across Japan, Germany and the U.S., although the letter does not restrict its ...

Dr David Johnson reviews findings from ACG 2026 on EoE, MASH, primary sclerosing cholangitis, and persistent reflux, plus ...

We are proud and excited to present this special edition and joint endeavor from the Society of Benign Prostate Disease (SoBPD) and Prostate Cancer and ...

Energy technology company Baker Hughes (NASDAQ:BKR) will be reporting earnings this Tuesday after the bell. Here’s what you ...

Vertiv Holdings Co. (NYSE: VRT), a global leader in critical digital infrastructure, today introduced the Vertiv™ SmartIT solution, a pre-engineered architecture designed to simplify high-density AI ...

The FDA's approval in tricuspid regurgitation adds the clip-based Pascal Precision alongside Edwards’ Evoque implant for replacing the valve.

The complete positive results from the Phase III Crossing study showed that tezepelumab achieved statistically significant and clinically relevant improvements in the co-primary endpoints of ...

Endo-TAGSS is the first percutaneous intragastric trocar that enables minimally invasive pyloroplasty for patients who don’t respond to prokinetic and antiemetic medications.